NARI

Insider Trades

Name	Value	Action	Price	Current Price
Hoffman WilliamDirector $8.5M141.1k shares SellJan 6, 2025 $60.13 --
Hoffman WilliamDirector $3.6M58.9k shares SellJan 6, 2025 $61.27 --
Hykes AndrewDirector, Officer: President And CEO $132k2.4k shares SellDec 20, 2024 $55.20 --
Hykes AndrewDirector, Officer: President And CEO $33k600 shares SellDec 20, 2024 $55.65 --
Hoffman WilliamDirector $1.2M20.9k shares SellDec 16, 2024 $55.23 --
Hoffman WilliamDirector $765k13.6k shares SellDec 16, 2024 $56.45 --

Trade NARI

About Inari Medical, Inc.

Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.

CEO: Kevin Strange
IPO Date: May 22, 2020

Market Data

Open: $79.96
High: $79.97
Low: $79.96
Volume: 2.4M
Avg Volume: 2.4M
52W High: $79.99
52W Low: $36.73

Valuation

Market Cap: $4.7B
Enterprise Value: $4.7B
Dividend Yield: 0.00%

Financials

Free Cash Flow: $30M
Revenue: $494M
Net Income: $-1.6M
Cash: $39M
Debt: $32M

Events

EarningsFeb 26

EPS est. -0.01 · actual 0.05